{
  "meta": {
    "title": "39_Biochemistry_Neet_2021",
    "url": "https://brainandscalpel.vercel.app/39-biochemistry-neet-2021-8486030d.html",
    "scrapedAt": "2025-11-30T12:57:56.541Z"
  },
  "questions": [
    {
      "text": "An alcoholic patient presented with itchy lesions as shown in the image, He also has a red-colored beefy tongue. Which of the following histories would you like to additionally ask/ elicit in this patient?",
      "choices": [
        {
          "id": 1,
          "text": "Ask for diarrhea and history of memory loss"
        },
        {
          "id": 2,
          "text": "Ask for diarrhea, thiamine deficiency features, and detailed dietary history"
        },
        {
          "id": 3,
          "text": "History of allergy"
        },
        {
          "id": 4,
          "text": "Ask for diarrhea and conjunctivitis"
        }
      ],
      "correct_choice_id": 1,
      "solution": "<p>An alcoholic patient with a <strong>red-colored beefy tongue</strong>, itching and the characteristic <strong>Casal's necklace, </strong>shown in the image, is suggestive of <strong>pellagra.</strong> It is<strong> </strong>caused by <strong>niacin/vitamin B3 deficiency.</strong> Hence, one should ask for a <strong>history </strong>of <strong>diarrhea </strong>and<strong> memory loss</strong> in this case.</p>\n<p>Pellagra presents with <strong>4 Ds: </strong>Diarrhea, Dermatitis, Dementia, and if untreated, Death. Early symptoms of pellagra are loss of appetite, generalized weakness and irritability, abdominal pain, and vomiting.<strong> </strong><strong>Photosensitive dermatitis </strong>is seen over sun-exposed areas. <strong>Diarrhea</strong> occurs due to proctitis or malabsorption. <strong>Bright red glossitis </strong>(beefy tongue) and <strong>Casal’s necklace </strong>(a pigmented, scaly skin rash that forms a ring around the neck) follow. Depressive psychosis and dementia also commonly occur.</p>\n<p><strong>Corn/ maize/ jowar</strong> based diets are the main causes of niacin deficiency. Corn/maize lacks niacin and tryptophan. The excess leucine in jowar and maize disrupts the conversion of tryptophan to niacin. Niacin deficiency is also seen in alcoholism. Hence, additional histories of diarrhea and memory loss will aid in supporting the diagnosis of pellagra (along with dietary history).</p>\n<p><strong>Treatment</strong> includes oral supplementation with 100–200 mg of <strong>nicotinamide</strong> or <strong>nicotinic acid</strong> three times daily for 5 days.</p>\n<p>Option B: <strong>Thiamine deficiency</strong> (vitamin B1) features include CVS manifestations like heart failure and edema (wet beriberi), peripheral neuritis (dry beriberi), and Wernicke encephalopathy (in alcoholics).</p>\n<p>Option C: <strong>Dermatitis </strong>seen in pellagra is due to dietary deficiency of niacin and so allergy history is not relevant.</p>\n<p>Option D: <strong>Conjunctivitis</strong> is not a feature of niacin deficiency.</p><hr><h3>Related Pearl: Vitamin Deficiency States (Water-soluble Vitamins)</h3><table>\n<tbody>\n<tr>\n<td>\n<p><strong>Vitamin</strong></p>\n</td>\n<td>\n<p><strong>Deficiency State</strong></p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Thiamine (<strong>B<sub>1</sub></strong>)</p>\n</td>\n<td>\n<p><strong>Beriberi</strong></p>\n<p>Wernicke&ndash;Korsakoff&rsquo;s syndrome</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Riboflavin (<strong>B<span>2</span></strong>)</p>\n</td>\n<td>\n<p>Cheilosis, Magenta-coloured tongue,&nbsp;</p>\n<p>Glossitis, Seborrheic dermatitis</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Niacin (<strong>B<span>3</span></strong>)</p>\n</td>\n<td>\n<p><strong>Pellagra</strong></p>\n<p>Dermatitis, Diarrhea, Dementia</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Pantothenic acid (<strong>B<span>5</span></strong>)</p>\n</td>\n<td>\n<p><strong>Burning foot syndrome</strong> (historically called as \"Nutritional melalgia\")</p>\n<div class=\"page\" title=\"Page 90\">\n<div class=\"section\">\n<div class=\"layoutArea\">\n<div class=\"column\">\n<p>Dermatitis, enteritis, alopecia, ataxia</p>\n</div>\n</div>\n</div>\n</div>\n</td>\n</tr>\n<tr>\n<td>\n<p>Pyridoxine (<strong>B<span>6</span></strong>)</p>\n</td>\n<td>\n<p>Microcytic anemia, convulsions, depression</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Biotin (<strong>B<span>7</span></strong>)</p>\n</td>\n<td>\n<p>Relatively unknown</p>\n<p>Dermatitis, atrophic glossitis, alopecia, paraesthesia, muscle pain, anorexia, hallucinations</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Folic acid (<strong>B<span>9</span></strong>)</p>\n</td>\n<td>\n<p>Megaloblastic anemia, neuropathy, neural tube defects, atrophic glossitis</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Cobalamin (<strong>B<span>12</span></strong>)</p>\n</td>\n<td>\n<p>Pernicious anemia, dementia, spinal cord degeneration, homocysteinemia</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Ascorbic acid (<strong>C</strong>)</p>\n</td>\n<td>\n<p><strong>Scurvy</strong></p>\n<p>Ecchymosis, bleeding gums, poor wound healing, fatigue, joint effusion, Scorbutic rosary</p>\n</td>\n</tr>\n</tbody>\n</table><div class=\"table-expand-wrapper\"><button type=\"button\" class=\"table-expand-btn glass-light\">Expand Table</button></div><hr><h3>Related Pearl: Conditions Associated with Pellagra-like Symptoms</h3><table>\n<tbody>\n<tr>\n<td>\n<p><strong>Condition/Disease</strong></p>\n</td>\n<td>\n<p><strong>Reason for niacin deficiency</strong></p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Hartnup disease</p>\n</td>\n<td>\n<p>Intestinal &amp; renal malabsorption of tryptophan</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Carcinoid syndrome</p>\n</td>\n<td>\n<p>Overproduction of serotonin that causes diversion of  tryptophan from NAD+ Pathway</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Vitamin B6 deficiency</p>\n</td>\n<td>\n<p>Defective kynureninase pathway</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Maize rich diet</p>\n</td>\n<td>\n<p>Niacin is in unavailable niacytin form</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Jowar diet (Sorghum)</p>\n</td>\n<td>\n<p>Increase leucine content inhibit QPRTase enzyme</p>\n</td>\n</tr>\n</tbody>\n</table><div class=\"table-expand-wrapper\"><button type=\"button\" class=\"table-expand-btn glass-light\">Expand Table</button></div>",
      "question_images": [
        "https://cdn1.dailyrounds.org/uploads/745692850c3b4fa897e04261e4486ac0.JPEG"
      ],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MF1327",
      "difficulty": "medium"
    },
    {
      "text": "A patient presented with symptoms of delayed adaptation to vision in dark places, gritty sensation in the eyes, dry eyes, and softening of the cornea. What is the likely deficiency in this case?",
      "choices": [
        {
          "id": 1,
          "text": "Retinoic acid"
        },
        {
          "id": 2,
          "text": "Riboflavin"
        },
        {
          "id": 3,
          "text": "Niacin"
        },
        {
          "id": 4,
          "text": "Pantothenic acid"
        }
      ],
      "correct_choice_id": 1,
      "solution": "<p>The clinical picture of delayed adaptation to vision in dark places, gritty sensation in the eyes, dry eyes, and softening of the cornea is suggestive of<strong> vitamin A deficiency</strong> in the patient. Hence <strong>retinoic acid</strong> (the active form of vitamin A) is likely to be deficient.</p>\n<p>Vitamin A is a <strong>fat-soluble</strong> vitamin that can occur as<strong> carotenoids</strong> (most common - beta carotene from plant sources) or <strong>retinoids</strong> (from animal sources).</p>\n<p>3 forms of retinoids are:</p>\n<ul>\n<li aria-level=\"1\"><strong>Retinal</strong> is required mainly for normal vision (present in the visual pigment rhodopsin).</li>\n<li aria-level=\"1\"><strong>Retinol</strong> is important for the normal functioning of the reproductive system.</li>\n<li aria-level=\"1\"><strong>Retinoic acid</strong> has a role in the regulation of gene expression and tissue differentiation.</li>\n</ul>\n<p><strong>Ocular manifestations</strong> of vitamin A deficiency include loss of sensitivity to green light (earliest to appear), nyctalopia (night blindness), xerophthalmia.</p>\n<p><strong>Xerophthalmia</strong> includes conjunctival xerosis (dryness) with Bitot&rsquo;s spots (white patches of keratinized epithelium appearing on the sclera), corneal ulcers, and<strong> keratomalacia</strong> (softening of the cornea) that leads to corneal scarring and ultimately, <strong>blindness.</strong></p>\n<p>Other manifestations: General impairment of immunity, keratinization of skin (phrynoderma/toad skin).&nbsp;</p>\n<p>Treatment: The WHO recommended schedule for all patients above the age of 1 year (except women of reproductive age): <strong>200,000 IU of vitamin A orally </strong>or<strong> 100,000 IU by intramuscular injection</strong>&nbsp;should be given immediately on diagnosis<strong> (day 0)</strong> and repeated the following day <strong>(day 1)</strong> and <strong>1</strong><strong>4 days later.</strong><br /><br />Dietary sources of vitamin A are liver, fish, eggs, dark green, and deeply colored fruits and vegetables.</p>\n<p>&nbsp;</p><p>Bitot's spots</p><img src=\"https://dhmbxeygs57ff.cloudfront.net/uploads/5db13c9a5910435c8763905c3415ce93x720x472.JPEG\" alt=\"Explanation Image\"><p>&nbsp;</p>\n<p>The below image shows phrynoderma with multiple keratotic papules</p><img src=\"https://dhmbxeygs57ff.cloudfront.net/uploads/a105b215ee4e476cb97f9832c89c5d61x720x434.PNG\" alt=\"Explanation Image\"><p>&nbsp;</p>\n<p>Other options:</p>\n<p>Option B: Ocular manifestations of riboflavin deficiency (vitamin B2) are photophobia, burning sensation, and vascularization of the cornea. Other features include cheilosis, magenta-colored tongue, glossitis, and seborrheic dermatitis.</p>\n<p>Corneal vascularization. Seen in riboflavin (Vitamin B2) deficiency.</p><img src=\"https://dhmbxeygs57ff.cloudfront.net/uploads/e9bac5b1a9e34c8cb4f79c8eb1cad7b7x720x678.JPEG\" alt=\"Explanation Image\"><p>&nbsp;</p>\n<p>Option C: Niacin deficiency (vitamin B3) leads to pellagra. Dermatitis, diarrhea, and dementia are its common features.</p>\n<p>Casal&rsquo;s necklace finding in niacin deficiency</p><img src=\"https://dhmbxeygs57ff.cloudfront.net/uploads/8ecf379ba9704f6fb6ba3584d71d0647x720x521.JPEG\" alt=\"Explanation Image\"><p>&nbsp;</p>\n<p>Option D: Features of pantothenic acid deficiency (vitamin B5) are burning foot syndrome ( \"nutritional melalgia\"), dermatitis, enteritis, alopecia, ataxia.</p><hr><h3>Related Pearl: WHO grading of Vitamin A deficiency</h3><p>The term xerophthalmia is reserved to cover all the ocular manifestations of vitamin A deficiency.</p>\n<table>\n<tbody>\n<tr>\n<td><strong>Stage</strong></td>\n<td><strong>Features</strong></td>\n<td><strong>Pathophysiology</strong></td>\n</tr>\n<tr>\n<td><strong>XN</strong></td>\n<td>Night blindness</td>\n<td>Lack of rhodopsin</td>\n</tr>\n<tr>\n<td><strong>X1A</strong></td>\n<td>Conjunctival Xerosis</td>\n<td>Conjunctival epithelial alteration, loss of goblet cells</td>\n</tr>\n<tr>\n<td><strong>X1B</strong></td>\n<td><strong>Bitot&rsquo;s spots</strong></td>\n<td>Conjunctival keratinization and plaque formation</td>\n</tr>\n<tr>\n<td><strong>X2</strong></td>\n<td>Corneal xerosis</td>\n<td>Corneal epithelial alteration</td>\n</tr>\n<tr>\n<td><strong>X3A</strong></td>\n<td>Corneal ulceration/ Keratomalacia affecting &lt;1/3<sup>rd</sup> of the corneal surface</td>\n<td>Liquefaction of corneal stroma</td>\n</tr>\n<tr>\n<td><strong>X3B</strong></td>\n<td>Corneal ulceration/ Keratomalacia affecting &gt;1/3<sup>rd</sup> of the corneal surface</td>\n<td>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; -</td>\n</tr>\n<tr>\n<td><strong>XS</strong></td>\n<td>Corneal scar</td>\n<td>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; -</td>\n</tr>\n<tr>\n<td><strong>XF</strong></td>\n<td>Xerophthalmic fundus</td>\n<td>Degeneration of the retinal pigment epithelium</td>\n</tr>\n</tbody>\n</table><div class=\"table-expand-wrapper\"><button type=\"button\" class=\"table-expand-btn glass-light\">Expand Table</button></div>\n<p>&nbsp;</p>\n<p><strong>The first symptom</strong>&nbsp;of xerophthalmia is&nbsp;<strong>nyctalopia.</strong></p>\n<p><strong>The first sign of</strong>&nbsp;xerophthalmia<strong>&nbsp;is&nbsp;conjunctival xerosis.</strong></p>\n<p>The&nbsp;<strong>pathognomonic</strong>&nbsp;feature of<strong>&nbsp;xerophthalmia</strong>&nbsp;is the appearance of&nbsp;<strong>Bitot's spots.</strong></p>\n<p><strong>Note: </strong></p>\n<p>Up to Stage X2, the manifestations are <strong>reversible</strong> if treated with vitamin A supplements. Active conjunctival xerosis and Bitot&rsquo;s spots begin to resolve within 2&mdash;5 days after supplementation. Most will disappear within 2 weeks, although a significant proportion of temporal lesions may persist in shrunken form and may therefore not be&nbsp;completely reversible.</p><hr><h3>Related Pearl: Ophthalmic manifestation in vitamin deficiency</h3><table>\n<tbody>\n<tr>\n<td><strong>Vitamin deficiency</strong></td>\n<td><strong>Ophthalmic manifestation</strong></td>\n</tr>\n<tr>\n<td><strong>A</strong></td>\n<td>\n<ul>\n<li>Xerophthalmia</li>\n</ul>\n</td>\n</tr>\n<tr>\n<td><strong>B1</strong></td>\n<td>\n<ul>\n<li>Corneal anesthesia</li>\n<li>Conjunctival and corneal dystrophy</li>\n<li>Acute retrobulbar neuritis</li>\n</ul>\n</td>\n</tr>\n<tr>\n<td><strong>B2</strong></td>\n<td>\n<ul>\n<li>Photophobia</li>\n<li>Burning sensation</li>\n<li>Vascularization of the cornea</li>\n</ul>\n</td>\n</tr>\n<tr>\n<td><strong>B12</strong></td>\n<td>\n<ul>\n<li>Bilateral centrocecal scotoma</li>\n</ul>\n</td>\n</tr>\n<tr>\n<td><strong>C</strong></td>\n<td>\n<ul>\n<li>Hemorrhage in eye</li>\n</ul>\n</td>\n</tr>\n<tr>\n<td><strong>D</strong></td>\n<td>\n<ul>\n<li>Zonular cataract</li>\n<li>Papilledema</li>\n</ul>\n</td>\n</tr>\n</tbody>\n</table><div class=\"table-expand-wrapper\"><button type=\"button\" class=\"table-expand-btn glass-light\">Expand Table</button></div><hr><h3>Related Pearl: Vitamin-A supplementation & treatment of Vitamin-A deficiency</h3><table>\n<tbody>\n<tr>\n<td colspan=\"3\">\n<div><strong>Vitamin A supplementation</strong></div>\n</td>\n</tr>\n<tr>\n<td>\n<div><strong>Target group</strong></div>\n</td>\n<td>\n<div>6 to 11 months age</div>\n</td>\n<td>\n<div>12 to 59 month of age (1yr to 5yr)</div>\n</td>\n</tr>\n<tr>\n<td>\n<div><strong>Dose</strong></div>\n</td>\n<td>\n<div>100,000 IU (oral)</div>\n</td>\n<td>\n<div>200,000 IU (oral)</div>\n</td>\n</tr>\n<tr>\n<td>\n<div><strong>Frequency</strong></div>\n</td>\n<td>\n<div>Once</div>\n</td>\n<td>\n<div>Every 4&ndash;6 months</div>\n</td>\n</tr>\n</tbody>\n</table><div class=\"table-expand-wrapper\"><button type=\"button\" class=\"table-expand-btn glass-light\">Expand Table</button></div>\n<p>&nbsp;</p>\n<p><strong>Note</strong>: A total dose of&nbsp;<strong>17 lakh IU</strong> given as per the following schedule:</p>\n<ul>\n<li>100,000 IU is given with measles vaccine at 9 months</li>\n<li>200,000 IU is given with DPT booster at 15&ndash;18 months</li>\n<li>200,000 IU is given every 6 months (till 5years of age)</li>\n</ul>\n<p>&nbsp;</p>\n<table>\n<tbody>\n<tr>\n<td colspan=\"4\"><strong>Treatment </strong>of vitamin A<strong> deficiency</strong></td>\n</tr>\n<tr>\n<td><strong>Age</strong></td>\n<td>&lt; 6 months</td>\n<td>6-12 months</td>\n<td>&gt; 1 year</td>\n</tr>\n<tr>\n<td><strong>Dose</strong></td>\n<td>50,000 IU</td>\n<td>100,000 IU</td>\n<td>200,000 IU</td>\n</tr>\n</tbody>\n</table><div class=\"table-expand-wrapper\"><button type=\"button\" class=\"table-expand-btn glass-light\">Expand Table</button></div>\n<p>&nbsp;</p>\n<p><strong>Note:</strong> Route of administration is <strong>oral</strong>, in the form of retinyl palmitate.</p>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MF1330",
      "difficulty": "easy"
    },
    {
      "text": "You are conducting an experiment on mitochondrial respiration. You add malate/pyruvate and respiration is normal. You add succinate and respiration is normal. When you add another substance in the presence of pyruvate/succinate and malate, respiration is blocked. Which of the following substances is most likely added?",
      "choices": [
        {
          "id": 1,
          "text": "Rotenone"
        },
        {
          "id": 2,
          "text": "Antimycin A"
        },
        {
          "id": 3,
          "text": "Oligomycin"
        },
        {
          "id": 4,
          "text": "2,4-dinitrophenol"
        }
      ],
      "correct_choice_id": 3,
      "solution": "<p>In the experiment conducted on mitochondrial respiration, respiration will be blocked by the addition of <strong>oligomycin,</strong> an antibiotic, when added in the presence of pyruvate/ succinate and malate. Oligomycin <strong>inhibits oxidative phosphorylation</strong> in the mitochondria and hence <strong>blocks respiration.</strong></p>\n<p><strong>Electron transport chain (ETC)/respiratory chain</strong> is the final pathway by which all the electrons derived from the oxidation of carbohydrates, fatty acids, and amino acids are directed towards the <strong>final reaction with oxygen</strong>, to <strong>form water</strong> and adenosine triphosphate (<strong>ATP</strong>).</p>\n<p>The <strong>chemiosmotic theory</strong> states that the flow of electrons through the respiratory chain generates a proton motive force. This force drives the formation of ATP by the process of oxidative phosphorylation.</p>\n<table>\n<tbody>\n<tr>\n<td>Complexes of ETC</td>\n<td>&nbsp; &nbsp; Inhibitors</td>\n</tr>\n<tr>\n<td>Complex I: NADH-CoQ oxidoreductase</td>\n<td>Piericidin, amobarbital, rotenone</td>\n</tr>\n<tr>\n<td>Complex II: Succinate-CoQ reductase</td>\n<td>TTFA (thenoyltrifluoroacetone), carboxin, malonate</td>\n</tr>\n<tr>\n<td>Complex III: CoQH2-cytochrome c oxidoreductase</td>\n<td>BAL(British anti-lewisite), antimycin A</td>\n</tr>\n<tr>\n<td>Complex IV: cytochrome oxidase</td>\n<td>Hydrogen sulfide, carbon monoxide, cyanide</td>\n</tr>\n<tr>\n<td>Complex V (informally): ATP Synthase</td>\n<td>Atractyloside, oligomycin</td>\n</tr>\n</tbody>\n</table><div class=\"table-expand-wrapper\"><button type=\"button\" class=\"table-expand-btn glass-light\">Expand Table</button></div>\n<p><br />In the given experiment, <strong>malate and pyruvate</strong> are<strong> electron donors (NADH)</strong> at <strong>complex I</strong> of the ETC, and <strong>succinate</strong> is the <strong>electron donor (FADH2)</strong> at <strong>complex II.</strong> Normal respiration is observed on the addition of substances at both complexes I and II i.e., both <strong>oxygen consumption</strong> and<strong> ATP synthesis</strong> from ADP (adenosine diphosphate) take place.</p>\n<p><strong>Oligomycin</strong> is a <strong>competitive inhibitor</strong> of the Fo (oligomycin-sensitive) complex of <strong>ATP synthase (complex V)</strong> and<strong> blocks oxidation</strong> and <strong>phosphorylation</strong> by stopping the flow of protons through the ATP synthase enzyme complex. Hence the addition of oligomycin will<strong> inhibit complex V</strong> and <strong>stop respiration.</strong></p>\n<p><br />Other options:</p>\n<p>Options A and B:&nbsp;<strong>Rotenone</strong> (option A) if added, will inhibit complex I. Electron transfer before complex I will be blocked but not after. Hence, normal respiration will occur. Similarly, <strong>antimycin A</strong> (option B) inhibits complex III, and electron transfer prior to complex III will be blocked and not after. Hence, respiration will not be completely hindered.</p>\n<p>Option C:<strong> 2,4-dinitrophenol (DNP)</strong>&nbsp;is an uncoupler that dissociates oxidation in the respiratory chain from phosphorylation. Hence, <strong>respiration continues</strong> without ATP synthesis.</p><hr><h3>Related Pearl: Electron transport chain: components and its inhibitors</h3><img src=\"https://dhmbxeygs57ff.cloudfront.net/uploads/bcc617cb8a8343ff8c0208d7726a0ba7x1280x1468.JPEG\" alt=\"Pearl Image\"><img src=\"https://dhmbxeygs57ff.cloudfront.net/uploads/c87ed88288804113994e57192a28d6f8x1280x969.JPEG\" alt=\"Pearl Image\"><hr><h3>Related Pearl: Inhibitors of metabolic pathways</h3><p><strong>Inhibitors of glycolysis</strong></p>\n<table>\n<tbody>\n<tr>\n<td><strong>Agent</strong></td>\n<td><strong>Enzyme</strong></td>\n</tr>\n<tr>\n<td>Iodoacetate</td>\n<td>Glyceraldehyde 3-phosphate dehydrogenase</td>\n</tr>\n<tr>\n<td>Arsenate</td>\n<td>Phosphoglycerate kinase</td>\n</tr>\n<tr>\n<td>Fluoride</td>\n<td>Enolase</td>\n</tr>\n</tbody>\n</table><div class=\"table-expand-wrapper\"><button type=\"button\" class=\"table-expand-btn glass-light\">Expand Table</button></div>\n<p>&nbsp;</p>\n<p><strong>Inhibitors of TCA cycle</strong></p>\n<table>\n<tbody>\n<tr>\n<td><strong>Agent</strong></td>\n<td><strong>Enzyme</strong></td>\n</tr>\n<tr>\n<td>Fluoroacetate</td>\n<td>Aconitase</td>\n</tr>\n<tr>\n<td>\n<div class=\"page\" title=\"Page 176\">\n<div class=\"section\">\n<div class=\"layoutArea\">\n<div class=\"column\">\n<p>Arsenite</p>\n</div>\n</div>\n</div>\n</div>\n</td>\n<td>&alpha;-ketoglutarate dehydrogenase</td>\n</tr>\n<tr>\n<td>Malonate</td>\n<td>Succinate dehydrogenase</td>\n</tr>\n</tbody>\n</table><div class=\"table-expand-wrapper\"><button type=\"button\" class=\"table-expand-btn glass-light\">Expand Table</button></div>\n<p>&nbsp;</p>\n<p><strong>Inhibitors of electron transport</strong></p>\n<table>\n<tbody>\n<tr>\n<td><strong>Complex</strong></td>\n<td><strong>Inhibitors</strong></td>\n</tr>\n<tr>\n<td>Complex I</td>\n<td>Piercidin, Amobarbital, Rotenone</td>\n</tr>\n<tr>\n<td>Complex II</td>\n<td>TTFA, Carboxin, Malonate</td>\n</tr>\n<tr>\n<td>Complex III</td>\n<td>BAL, Antimycin A</td>\n</tr>\n<tr>\n<td>Complex IV</td>\n<td>Hydrogen sulphide, Carbon monoxide, Cyanide</td>\n</tr>\n</tbody>\n</table><div class=\"table-expand-wrapper\"><button type=\"button\" class=\"table-expand-btn glass-light\">Expand Table</button></div>\n<p>&nbsp;</p>\n<p><strong>Inhibitors of oxidative phosphorylation</strong></p>\n<table>\n<tbody>\n<tr>\n<td><strong>Agent</strong></td>\n<td><strong>Mechanism</strong></td>\n</tr>\n<tr>\n<td>Atractyloside</td>\n<td>Inhibits ADP and ATP Transporter</td>\n</tr>\n<tr>\n<td>Oligomycin</td>\n<td>Blocks flow of protons through Fo complex</td>\n</tr>\n</tbody>\n</table><div class=\"table-expand-wrapper\"><button type=\"button\" class=\"table-expand-btn glass-light\">Expand Table</button></div>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MF1337",
      "difficulty": "medium"
    },
    {
      "text": "A patient presented with tendon xanthomas. His lipid profile showed serum cholesterol levels to be 283 mg/dL and serum LDL to be 202 mg/dL. He was started on lovastatin. What is the likely diagnosis?<div class='question-desc-html'><p>LDL - Low density lipoprotein</p></div>",
      "choices": [
        {
          "id": 1,
          "text": "Familial hypercholesterolemia"
        },
        {
          "id": 2,
          "text": "Tangier's disease"
        },
        {
          "id": 3,
          "text": "Lipoprotein lipase deficiency"
        },
        {
          "id": 4,
          "text": "Familial hyperchylomicronemia"
        }
      ],
      "correct_choice_id": 1,
      "solution": "<p>The clinical presentation with <strong>tendon xanthomas</strong> and <strong>elevated serum LDL</strong> (low-density lipoprotein) and <strong>elevated serum cholesterol</strong> points to a diagnosis of <strong>familial hypercholesterolemia (FH).</strong></p>\n<p>Familial hypercholesterolemia &nbsp;(type IIa hyperlipoproteinemia) is an <strong>inherited disorder</strong> due to <strong>defects in LDL receptors</strong>. This defect causes a decrease in the uptake of LDL and cholesterol. As a result, the blood levels of both LDL and cholesterol are elevated. Such patients are at increased risk to develop <strong>atherosclerosis</strong> and <strong>coronary artery disease.</strong></p>\n<p>Features of FH:&nbsp;</p>\n<ul>\n<li>Painful polyarthritis and tendinitis are common.</li>\n<li>Physical findings seen are <strong>corneal arcus</strong>&nbsp;and&nbsp;<strong>tendon xanthomas</strong> over<strong> Achilles tendon</strong> and&nbsp;the dorsum of hands. Xanthomas are tumorous masses produced by foamy cell clusters (lipid-laden macrophages) found in the connective tissue of the skin and in tendons.</li>\n</ul>\n<p>Diagnosis is done clinically based on hypercholesterolemia with&nbsp;</p>\n<ul>\n<li aria-level=\"1\">LDL <strong>&gt; 190 mg/dl</strong>,&nbsp;</li>\n<li aria-level=\"1\">Family history of hypercholesterolemia and/or</li>\n<li aria-level=\"1\">Premature coronary artery disease.</li>\n</ul>\n<p>Treatment includes lifestyle changes, restriction of a fatty diet, and pharmacotherapy with <strong>statins</strong> in heterozygous FH patients.</p>\n<p>Recent drugs for specific treatment of homozygous FH are:</p>\n<ul>\n<li aria-level=\"1\"><strong>Lomitapide</strong>, a microsomal triglyceride transfer protein (MTP) inhibitor, and</li>\n<li aria-level=\"1\"><strong>Mipomersen</strong>, an antisense oligonucleotide against apoB.</li>\n</ul>\n<p>The image below shows Achilles tendon xanthoma and a plain lateral radiograph of both ankles showing bilateral symmetrical swellings (arrows) superior to the calcaneum respectively.</p>\n<p>&nbsp;</p><img src=\"https://dhmbxeygs57ff.cloudfront.net/uploads/864ecc007850432da511921ae29204c9x284x178.PNG\" alt=\"Explanation Image\"><img src=\"https://dhmbxeygs57ff.cloudfront.net/uploads/3a4d2e15aa1c430891887f2f5685ec09x512x416.PNG\" alt=\"Explanation Image\"><p>&nbsp;</p>\n<p>Other options</p>\n<p>Option B: <strong>Tangier&rsquo;s disease</strong> is a hypolipoproteinemia caused by a mutation of the <strong>ABCA1 gene</strong>. Enlarged <strong>orange tonsils</strong> are pathognomonic. <strong>Low HDL</strong> levels are seen. There is an increased risk for atherosclerosis.</p>\n<p>The image below shows enlarged yellow-orange colored tonsils in Tangier's disease.</p><img src=\"https://dhmbxeygs57ff.cloudfront.net/uploads/dd350316b6c9423d8b3a4b0547759642x225x225.JPEG\" alt=\"Explanation Image\"><p>&nbsp;</p>\n<p>Option C: <strong>Lipoprotein lipase (LPL) deficiency</strong> causes type I hyperlipoproteinemia due to <strong>defects in LPL</strong> or <strong>apo C-II.</strong> <strong>Eruptive xanthomas</strong> are seen. <strong>Chylomicrons</strong> and <strong>VLDL</strong> are elevated. <strong>LDL</strong> and <strong>HDL</strong> are<strong> low.</strong> There is no risk for coronary disease.</p><p>Option D:<strong> Familial hyperchylomicronemia syndrome</strong> is caused due to either&nbsp;<strong>LPL deficiency</strong>,&nbsp;<strong>ApoC-II deficiency</strong>,&nbsp;<strong>ApoA-V deficiency,</strong>&nbsp;or&nbsp;<strong>GPIHBP1 mutation.</strong>&nbsp;Clinically, patients present with&nbsp;recurrent episodes of severe abdominal pain due to&nbsp;<strong>acute pancreatitis</strong>.&nbsp;The retinal blood vessels may be opalescent and are called&nbsp;<strong>lipemia retinalis</strong>. Increased levels of triglycerides (mostly &gt;1000 mg/dL) is seen. The risk of premature coronary heart disease is low.</p><hr><h3>Related Pearl: Familial Dyslipidemias</h3><table>\n<tbody>\n<tr>\n<td>Type</td>\n<td>Increased levels&nbsp;</td>\n<td>Manifestation</td>\n</tr>\n<tr>\n<td>1. Hyperchylomicronemia(type I hyperlipoproteinemia)</td>\n<td>Chylomicrons, VLDL, TG&nbsp;</td>\n<td>Pancreatitis, hepatosplenomegaly, and xanthomas</td>\n</tr>\n<tr>\n<td>2.&nbsp;Familial hypercholesterolemia(type II&nbsp;hyperlipoproteinemia)</td>\n<td>LDL and cholesterol</td>\n<td>Atherosclerosis and xanthomas</td>\n</tr>\n<tr>\n<td>3. Dysbetalipoproteinemia(type III hyperlipoproteinemia)</td>\n<td>Chylomicrons and VLDL</td>\n<td>Atherosclerosis and xanthomas</td>\n</tr>\n<tr>\n<td>4. Hypertriglyceridemia(type IV hyperlipoproteinemia)</td>\n<td>VLDL and TG</td>\n<td>Pancreatitis</td>\n</tr>\n</tbody>\n</table><div class=\"table-expand-wrapper\"><button type=\"button\" class=\"table-expand-btn glass-light\">Expand Table</button></div>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MF1334",
      "difficulty": "easy"
    },
    {
      "text": "Which of the following glycosaminoglycans (GAGs) are responsible for corneal transparency?",
      "choices": [
        {
          "id": 1,
          "text": "Keratan sulfate"
        },
        {
          "id": 2,
          "text": "Chondroitin sulfate"
        },
        {
          "id": 3,
          "text": "Heparan sulfate"
        },
        {
          "id": 4,
          "text": "Hyaluronic acid"
        }
      ],
      "correct_choice_id": 1,
      "solution": "<p>The glycosaminoglycan (GAG) responsible for corneal transparency is <strong>keratan sulfate.</strong></p>\n<p><strong>Glycosaminoglycans</strong> or<strong> mucopolysaccharides</strong> are complex carbohydrates made up of <strong>amino sugars</strong> and <strong>uronic acids.</strong> They may be attached to a protein molecule to form a <strong>proteoglycan.</strong>&nbsp;</p>\n<p>Keratan sulfate is a mucopolysaccharide that does<strong> not</strong> contain <strong>uronic acid.</strong> It is constituted by repeating disaccharide units of <strong>N-acetyl glucosamine</strong> and <strong>galactose.</strong></p>\n<p>Keratan sulfate is present between the collagen fibrils in the cornea and plays a major role in <strong>corneal transparency.</strong></p>\n<p>&nbsp;<strong>2 types of keratan sulfate are seen:<br /></strong></p>\n<ul>\n<li aria-level=\"1\">Keratan sulfate I is present in the <strong>cornea.</strong></li>\n<li aria-level=\"1\">Keratan sulfate II is mainly present in the <strong>cartilage.</strong></li>\n</ul>\n<p>Keratin sulfate I and II differ in their linkage to the core proteins. Keratan sulfate I links to a core protein <strong>L-asparagine via N-acetylglucosamine</strong> and Keratan sulfate II to&nbsp; <strong>L-Serine (or L-Threonine) via N-acetylgalactosamine.</strong></p>\n<p>The chemical structure of Keratan sulfate is shown in the image below.</p><img src=\"https://dhmbxeygs57ff.cloudfront.net/uploads/998a1a25cb394a3c83a5408d1dd4ec2bx412x255.JPEG\" alt=\"Explanation Image\"><p>&nbsp;</p>\n<p>Other options:</p>\n<p>Option B: In <strong>chondroitin sulfates</strong> (chondroitin 4-Sulfate &amp; chondroitin 6-Sulfate), the repeating disaccharide units are <strong>glucuronic acid</strong> and <strong>N-acetylgalactosamine.&nbsp;</strong> They maintain the structure of the<strong> extracellular matrix (ECM)</strong> and are located in <strong>endochondral bone</strong> and <strong>cartilage.</strong> They are also found in the ECM of the central nervous system. They act as signaling molecules in the prevention of the repair of nerve endings after injury.</p>\n<p>Option C: <strong>Heparan sulfate</strong> is found on many extracellular cell surfaces and contains <strong>glucosamine</strong> with fewer N-sulfates than heparin. The predominant uronic acid is <strong>d-glucuronic acid.</strong>&nbsp;In the plasma membrane of cells, they act as receptors and mediate cell growth and cell-cell communication. It is also found in the <strong>basement membrane</strong> of the <strong>kidney</strong> along with type IV collagen and laminin, where it determines the charge selectiveness of glomerular filtration.</p>\n<p>Option D: <strong>Hyaluronic acid</strong> is present in <strong>synovial fluid.</strong> It is also found in skin, bone, cartilage, vitreous humor, and embryonic tissues. It contains repeating units of<strong> N Acetyl Glucosamine</strong> and <strong>glucuronic acid.</strong> It plays a role in morphogenesis and wound repair. The high concentrations of hyaluronic acid along with chondroitin sulfates in <strong>cartilage</strong> contribute to its <strong>compressibility.</strong></p><hr><h3>Related Pearl: Biologically important Glycosoaminoglycans(GAG's)</h3><table>\n<tbody>\n<tr>\n<td>\n<p><strong>GAG</strong></p>\n</td>\n<td>\n<p><strong>Disaccharide repeat units</strong></p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Keratan sulfate</p>\n</td>\n<td>\n<p>N Acetyl Glucosamine + Galactose</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Hyaluronic acid</p>\n</td>\n<td>\n<p>N Acetyl Glucosamine + Glucuronic acid</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Chondroitin sulfate</p>\n</td>\n<td>\n<p>N Acetyl Galactosamine + Glucuronic acid</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Dermatan Sulfate</p>\n</td>\n<td>\n<p>N Acetyl Galactosamine + Iduronic/ Glucuronic acid</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Heparan sulfate</p>\n</td>\n<td>\n<p>N Acetyl(Fewer N-sulphated than Heparin)Glucosamine&nbsp;+ Glucuronic acid</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Heparin</p>\n</td>\n<td>\n<p>N Sulphated Glucosamine + Iduronic acid</p>\n</td>\n</tr>\n</tbody>\n</table><div class=\"table-expand-wrapper\"><button type=\"button\" class=\"table-expand-btn glass-light\">Expand Table</button></div><hr><h3>Related Pearl: MPS and Their Respective Enzyme Deficiencies</h3><table>\n<tbody>\n<tr>\n<td><strong>Disease</strong></td>\n<td><strong>MPS</strong></td>\n<td><strong>Enzyme defective</strong></td>\n<td><strong>GAGs affected</strong></td>\n<td><strong>Symptoms</strong></td>\n</tr>\n<tr>\n<td>Hurler-, Scheie-,&nbsp;<br />Hurler-scheie syndrome</td>\n<td>MPS I</td>\n<td>&alpha;-L-Iduronidase</td>\n<td>\n<p>Dermatan sulfate,<br />Heparan sulfate</p>\n</td>\n<td>Mental retardation,<br />coarse facial features,&nbsp;<br />Hepatosplenomegaly<br />Cloudy cornea</td>\n</tr>\n<tr>\n<td>Hunter syndrome</td>\n<td>MPS II</td>\n<td>Iduronate sulfatase</td>\n<td>Dermatan sulfate,&nbsp;<br />Heparan sulfate</td>\n<td>Mental retardation</td>\n</tr>\n<tr>\n<td>Sanfilippo&nbsp;syndrome A</td>\n<td>MPS IIIA</td>\n<td>Heparan sulfate-N-sulfatase</td>\n<td>Heparan sulfate</td>\n<td>Delay in development<br />Motor dysfunction</td>\n</tr>\n<tr>\n<td>Sanfilippo&nbsp;syndrome B</td>\n<td>MPS III B</td>\n<td>&alpha;-N-Acetylglucosaminidase</td>\n<td>Heparan sulfate</td>\n<td>As MPS III A</td>\n</tr>\n<tr>\n<td>Sanfilippo&nbsp;syndrome C</td>\n<td>MPS III C</td>\n<td>&alpha;-glucosaminide N-acetyltransferase</td>\n<td>Heparan sulfate</td>\n<td>As MPS III A &nbsp;</td>\n</tr>\n<tr>\n<td>Sanfilippo&nbsp;syndrome D</td>\n<td>MPS III D</td>\n<td>N-acetylglucosamine 6-sulfatase</td>\n<td>Heparan sulfate</td>\n<td>As MPS III A &nbsp;</td>\n</tr>\n<tr>\n<td>Morquio syndrome A</td>\n<td>MPS IV A</td>\n<td>Galactosamine&nbsp;6-sulfatase</td>\n<td>Keratan sulfate&nbsp;<br />Chondroitin 6-sulfate&nbsp;</td>\n<td>Skeletal dysplasia<br />short stature</td>\n</tr>\n<tr>\n<td>Morquio syndrome B</td>\n<td>MPS IV B</td>\n<td>&beta;-galactosidase</td>\n<td>Keratan sulfate</td>\n<td>As MPS IV A</td>\n</tr>\n<tr>\n<td>Maroteaux-lamy&nbsp;syndrome&nbsp;</td>\n<td>MPS VI</td>\n<td>N-acetylgalactosamine 4-sulfatase</td>\n<td>Dermatan sulfate</td>\n<td>Curvature of the spine,<br />Short stature<br />Skeletal dysplasia<br />Cardiac defects</td>\n</tr>\n<tr>\n<td>Sly&nbsp;syndrome&nbsp;</td>\n<td>MPS VII</td>\n<td>&beta;-glucuronidase</td>\n<td>Dermatan sulfate<br />Heparan sulfate<br />Chondroitin 4-sulfate&nbsp;<br />Chondroitin 6-sulfate&nbsp;<br /><br /></td>\n<td>Short stature<br />Skeletal dysplasia<br />Hepatomegaly<br />Cloudy cornea</td>\n</tr>\n<tr>\n<td>Natowicz&nbsp;syndrome&nbsp;</td>\n<td>MPS IX</td>\n<td>Hyaluronidase</td>\n<td>Hyaluronic acid</td>\n<td>Joint Pain<br />Short stature&nbsp;</td>\n</tr>\n</tbody>\n</table><div class=\"table-expand-wrapper\"><button type=\"button\" class=\"table-expand-btn glass-light\">Expand Table</button></div>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MF1305",
      "difficulty": "easy"
    },
    {
      "text": "A person who had dinner at 8 pm the previous night, tested his blood glucose levels at 7 am the next morning. What is the source of blood glucose in this case?",
      "choices": [
        {
          "id": 1,
          "text": "Hepatic glycogenolysis"
        },
        {
          "id": 2,
          "text": "Hepatic gluconeogenesis"
        },
        {
          "id": 3,
          "text": "Muscle glycogenolysis"
        },
        {
          "id": 4,
          "text": "Dietary glucose"
        }
      ],
      "correct_choice_id": 1,
      "solution": "<p>The source of blood glucose in a person<strong> fasting overnight</strong> for 11 hours (8 pm to 7 am) is<strong> hepatic glycogenolysis.</strong></p>\n<p>First stage of fasting: The fasting state begins <strong>two to four hours</strong> after the <strong>absorptive/well-fed state.</strong> In early fasting i.e; <strong>4-18 hours after the well-fed state,</strong> the blood glucose level is maintained by hepatic glycogenolysis. The glycogen stores are sufficient for around 18 hours after a meal following which they start to deplete. So the source of blood glucose in a person fasting for 11 hours will be liver glycogenolysis.<br /><br />Second stage of fasting:&nbsp;<strong>Gluconeogenesis</strong> begins 4&ndash;6 hours after the last meal but becomes fully active only after stores of liver glycogen are depleted<strong> (after 18 hours)</strong>. They can serve as a source of glucose for up to 2 days.</p>\n<p>Substrates for gluconeogenesis are:</p>\n<ul>\n<li aria-level=\"1\"><strong>Glucogenic amino acids</strong> ( mainly alanine) from the muscle and</li>\n<li aria-level=\"1\"><strong>Glycerol</strong> from adipose tissue&nbsp;</li>\n</ul>\n<p>During fasting, the glucogenic amino acids are transported to the liver, transaminated into pyruvate, and converted to glucose.</p>\n<p>Third stage of fasting:</p>\n<ul>\n<li aria-level=\"1\"><strong>Lipolysis</strong>&nbsp;occurs in the adipose tissue due to the activity of <strong>hormone-sensitive lipase,</strong> stimulated by <strong>increased glucagon:insulin ratio.</strong></li>\n<li aria-level=\"1\"><strong>Free fatty acids</strong> are the source of energy in this stage and not glucose. Triacylglycerols will be hydrolyzed to fatty acids and glycerol.&nbsp;</li>\n<li aria-level=\"1\"><strong>Beta oxidation</strong> of fatty acids takes place which provides <strong>acetyl CoA.&nbsp;</strong></li>\n<li aria-level=\"1\">In prolonged starvation <strong>(&gt;3 days)</strong>, acetyl CoA is converted to <strong>ketone bodies</strong> in the liver which will act as the main fuel source for skeletal and heart muscle and can meet up to 20% of the brain&rsquo;s energy needs.</li>\n</ul>\n<p>Final stage of fasting: After several weeks of starvation, ketone body synthesis will not take place due to depleted triacylglycerol stores. <strong>Proteins</strong> remain the only source of fuel. Protein degradation increases, and <strong>death</strong> results from a loss of heart, liver, or kidney function.</p>\n<p>Role of insulin and glucagon:</p>\n<p>When blood glucose falls during fasting, there is <strong>increased</strong> secretion of <strong>glucagon</strong> and <strong>decreased</strong> release of <strong>insulin.</strong> Hence <strong>glucagon:insulin ratio</strong> is <strong>increased.</strong></p>\n<p>Effects of increased glucagon:insulin ratio on enzymes of glycogenolysis and gluconeogenesis:</p>\n<ol>\n<li aria-level=\"1\">It activates <strong>glycogen phosphorylase,</strong> the key enzyme of glycogenolysis, and deactivates glycogen synthase. This causes a rapid mobilization of liver glycogen stores to be utilized as fuel.</li>\n<li aria-level=\"1\">It favors the synthesis of <strong>glucose-6-phosphatase</strong> which converts glucose-6-phosphate to glucose. The resulting glucose is used by<strong> red blood cells</strong> (lack mitochondria) and the <strong>brain</strong> as they are largely dependant on glucose in the fasting state.</li>\n<li aria-level=\"1\"><strong>Phosphoenol pyruvate carboxykinase</strong> and <strong>fructose-1, 6-bisphosphatase</strong> are induced, leading to<strong> increased gluconeogenesis.</strong></li>\n</ol>\n<table>\n<tbody>\n<tr>\n<td>Metabolic process&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</td>\n<td>Fasting state&nbsp; &nbsp;</td>\n<td>&nbsp; Fed state</td>\n</tr>\n<tr>\n<td>Glucagon: insulin&nbsp;</td>\n<td>&nbsp;Increased&nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp;&nbsp;</td>\n<td>&nbsp;Decreased</td>\n</tr>\n<tr>\n<td>Gluconeogenesis&nbsp;&nbsp;</td>\n<td>&nbsp;Increased&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</td>\n<td>&nbsp;Decreased&nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp;&nbsp;</td>\n</tr>\n<tr>\n<td>Glycogenolysis</td>\n<td>&nbsp;Increased&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</td>\n<td>&nbsp;Decreased</td>\n</tr>\n<tr>\n<td>Ketogenesis</td>\n<td>&nbsp;Increased&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</td>\n<td>&nbsp;Decreased</td>\n</tr>\n<tr>\n<td>Glycogen storage</td>\n<td>&nbsp;Decreased</td>\n<td>&nbsp;Increased&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</td>\n</tr>\n</tbody>\n</table><div class=\"table-expand-wrapper\"><button type=\"button\" class=\"table-expand-btn glass-light\">Expand Table</button></div><img src=\"https://dhmbxeygs57ff.cloudfront.net/uploads/ec0f7f37d46b43aba5d8a67df102de0cx1280x1901.JPEG\" alt=\"Explanation Image\"><p>Other options:</p>\n<p>Option C: <strong>Muscle glycogen</strong> cannot contribute directly to plasma glucose, since muscle lacks glucose-6-phosphatase. So glycogen cannot be converted to glucose to be used as fuel during starvation.&nbsp;</p>\n<p>Option D: In the <strong>well-fed state/ absorptive state</strong> of<strong> two to four hours</strong> after a meal, <strong>dietary glucose</strong> is the main source of fuel.</p><p>The below image shows steps of glycolysis and gluconeogenesis.</p><img src=\"https://dhmbxeygs57ff.cloudfront.net/uploads/0d210dea707846be8a80b1dd085abdacx600x1200.JPEG\" alt=\"Explanation Image\"><hr><h3>Related Pearl: Rate determining enzymes and their key regulators</h3><table>\n<tbody>\n<tr>\n<td>Pathway</td>\n<td>Enzyme&nbsp;</td>\n<td>Regulating factors</td>\n</tr>\n<tr>\n<td>Glycolysis</td>\n<td>Phosphofructokinase (PFK-1)</td>\n<td>\n<p>AMP+, Fructose 2,6 bi-phosphate+</p>\n<p>ATP-, Citrate-</p>\n</td>\n</tr>\n<tr>\n<td>&nbsp;gluconeogenesis</td>\n<td>Fructose-1,6-bisphosphatase</td>\n<td>\n<p>ATP+, Acetyl CoA+</p>\n<p>AMP-, Fructose 2,6 bi-phosphate-</p>\n</td>\n</tr>\n<tr>\n<td>&nbsp;Krebs cycle</td>\n<td>Isocitrate dehydrogenase</td>\n<td>\n<p>ADP+,</p>\n<p>ATP-, NADH-</p>\n</td>\n</tr>\n<tr>\n<td>&nbsp;glycogenesis</td>\n<td>Glycogen synthase</td>\n<td>\n<p>Glucose-6-phosphate+, insulin+, cortisol+,</p>\n<p>Epinephrine-, glucagon-</p>\n</td>\n</tr>\n<tr>\n<td>&nbsp;glycogenolysis</td>\n<td>Glycogen phosphorylase</td>\n<td>\n<p>Epinephrine+, glucagon+, AMP+</p>\n<p>Glucose-6-phosphate-, insulin-, ATP-</p>\n</td>\n</tr>\n<tr>\n<td>HMP shunt&nbsp;</td>\n<td>Glucose-6-phosphate dehydrogenase (G6PD)</td>\n<td>\n<p>NADP+</p>\n<p>NADPH-</p>\n</td>\n</tr>\n<tr>\n<td>&nbsp;Denovo pyrimidine synthesis</td>\n<td>Carbamoyl phosphate synthetase II</td>\n<td>\n<p>ATP+</p>\n<p>UTP-</p>\n</td>\n</tr>\n<tr>\n<td>&nbsp;Denovo purine synthesis</td>\n<td>Glutamine-phosphoribosylpyrophosphate (PRPP) amidotransferase</td>\n<td>AMP-, IMP-, GMP-</td>\n</tr>\n<tr>\n<td>&nbsp;Urea cycle</td>\n<td>Carbamoyl phosphate synthetase I</td>\n<td>N-acetyl glutamate (NAG)+</td>\n</tr>\n<tr>\n<td>&nbsp;Fatty acid synthesis</td>\n<td>Acetyl-CoA carboxylase (ACC)</td>\n<td>\n<p>Insulin+, citrate+</p>\n<p>Glucagon-, palmitoyl-CoA-</p>\n</td>\n</tr>\n<tr>\n<td>&nbsp;Fatty acid oxidation</td>\n<td>Carnitine acyltransferase I</td>\n<td>Malonyl-CoA-</td>\n</tr>\n<tr>\n<td>&nbsp;Cholesterol synthesis</td>\n<td>HMG-CoA reductase</td>\n<td>\n<p>Insulin+, thyroxine+</p>\n<p>Glucagon-, cholesterol-</p>\n</td>\n</tr>\n<tr>\n<td>Ketogenesis</td>\n<td>HMG-CoA synthase</td>\n<td>&nbsp;</td>\n</tr>\n</tbody>\n</table><div class=\"table-expand-wrapper\"><button type=\"button\" class=\"table-expand-btn glass-light\">Expand Table</button></div>\n<p>+ Positive effect on the pathway.</p>\n<p>- Negative effect on the pathway.</p>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MF1333",
      "difficulty": "medium"
    },
    {
      "text": "A patient who has been diagnosed with multiple gastrointestinal polyps and carcinoma, with a positive family history/history of hereditary non-polyposis colon carcinoma has a defect in which of the following?",
      "choices": [
        {
          "id": 1,
          "text": "Mismatch repair"
        },
        {
          "id": 2,
          "text": "Nucleotide excision repair"
        },
        {
          "id": 3,
          "text": "Base excision repair"
        },
        {
          "id": 4,
          "text": "Point mutation"
        }
      ],
      "correct_choice_id": 1,
      "solution": "<p><strong>Mismatch repair</strong> will be defective in a patient with multiple gastrointestinal polyps and carcinoma, with a positive family history/history of <strong>hereditary non-polyposis colon carcinoma </strong>(HNPCC)</p>\n<p><strong>Mismatch repair </strong>is a DNA repair mechanism that corrects single-nucleotide mismatches, insertions, and deletions introduced by the DNA polymerase during DNA replication.</p>\n<p>HNPCC or <strong>Lynch syndrome</strong> is an <strong>autosomal dominant</strong> genetic condition. It occurs due to <strong>defects</strong> in DNA mismatch repair genes like <strong>MLH1</strong> and <strong>MSH2</strong>. The genomes of these patients show <strong>microsatellite instability</strong>. HNPCC is associated with a high risk of <strong>colon cancer. </strong>It may also be associated with a risk of developing carcinomas of the endometrium, stomach, small bowel, ovary, pancreas, and transitional cell carcinoma of the ureter and renal pelvis.</p>\n<p>The diagnostic criteria for HNPCC are referred to as the <strong>Amsterdam criteria</strong> or the <strong>3-2-1-0 rule. </strong>It includes:</p>\n<ul>\n<li aria-level=\"1\"><strong>Three </strong>or<strong> more relatives</strong> with HNPCC-associated cancer (colorectal cancer, endometrial cancer, cancer of the small bowel, ureter, or renal pelvis), one of whom is a <strong>first-degree relative</strong> of the other two.</li>\n<li aria-level=\"1\">At least <strong>two</strong> successive generations affected</li>\n<li aria-level=\"1\">At least <strong>one</strong> case diagnosed before age 50 years</li>\n<li aria-level=\"1\">Familial adenomatous polyposis <strong>excluded</strong></li>\n<li aria-level=\"1\">Tumors verified by pathologic examination.</li>\n</ul>\n<p>Other options:</p>\n<p>Option B: Patients with<strong> xeroderma pigmentosum</strong> have a defect in the <strong>nucleotide excision repair</strong> pathway.</p>\n<p>Option C: Defect in <strong>base excision repair</strong> pathway is seen in patients with <strong>MUTYH-associated polyposis.</strong></p>\n<p>Option D: <strong> Sickle cell disease</strong> and <strong>beta-thalassemia</strong> are examples of diseases seen in patients with <strong>point mutations.</strong></p><hr><h3>Related Pearl: Human Diseases of DNA Damage Repair</h3><table>\n<tbody>\n<tr>\n<td>\n<p><strong>DNA damage repair type</strong></p>\n</td>\n<td>\n<p><strong>Diseases</strong></p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Defective Nonhomologous End Joining Repair (NHEJ)</p>\n</td>\n<td>\n<p>Severe combined immunodeficiency disease (SCID)</p>\n<p>Radiation sensitive severe combined immunodeficiency disease(RS-SCID)</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Defective Homologous Repair (HR)</p>\n</td>\n<td>\n<p>AT-like disorder (ATLD)</p>\n<p>Nijmegen breakage syndrome (NBS)</p>\n<p>Bloom syndrome (BS)</p>\n<p>Werner syndrome (WS)</p>\n<p>Rothmund-Thomson syndrome (RTS)</p>\n<p>Breast cancer suspectibility 1 and 2 (BRCA1, BRCA2)</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Defective DNA Nucleotide Excision Repair (NER)</p>\n</td>\n<td>\n<p>Xeroderma pigmentosum (XP)</p>\n<p>Cockayne syndrome (CS)</p>\n<p>Trichothiodystrophy (TTD)</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Defective DNA Base Excision Repair (BER)</p>\n</td>\n<td>\n<p>MUTYH-associated polyposis (MAP)</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Defective DNA Mismatch Repair (MMR)</p>\n</td>\n<td>\n<p>Hereditary nonpolyposis colorectal cancer (HNPCC)</p>\n</td>\n</tr>\n</tbody>\n</table><div class=\"table-expand-wrapper\"><button type=\"button\" class=\"table-expand-btn glass-light\">Expand Table</button></div><hr><h3>Related Pearl: DNA Repair Mechanisms</h3><table>\n<tbody>\n<tr>\n<td><strong>Damaging agents</strong></td>\n<td><strong>Damage caused</strong></td>\n<td><strong>Repair mechanisms</strong></td>\n</tr>\n<tr>\n<td>\n<p>Ionizing radiation</p>\n<p>X-rays</p>\n<p>Anti-tumor drugs</p>\n</td>\n<td>\n<p>Double-strand breaks</p>\n<p>Single-strand breaks</p>\n<p>Intrastrand crosslinks</p>\n<p>Interstrand crosslinks</p>\n</td>\n<td>Non-homologous end joining (NHEJ)</td>\n</tr>\n<tr>\n<td>\n<p>UV light</p>\n<p>Chemicals</p>\n</td>\n<td>\n<p>Bulky adducts</p>\n<p>Pyrimidine dimers</p>\n</td>\n<td>Nucleotide excision repair (NER)</td>\n</tr>\n<tr>\n<td>\n<p>Oxygen radicals</p>\n<p>Hydrolysis&nbsp;</p>\n<p>Alkylating agents</p>\n</td>\n<td>\n<p>Abasic sites single-strand breaks</p>\n<p>8-oxoguanine lesions</p>\n</td>\n<td>Base excision repair (BER)</td>\n</tr>\n<tr>\n<td>Replication errors</td>\n<td>\n<p>Bases mismatch</p>\n<p>Insertions</p>\n<p>Deletions</p>\n</td>\n<td>Mismatch repair (MMR)</td>\n</tr>\n</tbody>\n</table><div class=\"table-expand-wrapper\"><button type=\"button\" class=\"table-expand-btn glass-light\">Expand Table</button></div>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MF1309",
      "difficulty": "medium"
    },
    {
      "text": "The enzymes that convert pyruvate to acetyl CoA are given in the diagram. What are the enzymes marked as E1 and E2 respectively?",
      "choices": [
        {
          "id": 1,
          "text": "Pyruvate dehydrogenase and dihydrolipoyl transacetylase"
        },
        {
          "id": 2,
          "text": "Pyruvate carboxylase and dihydrolipoyl transacetylase"
        },
        {
          "id": 3,
          "text": "Pyruvate dehydrogenase and dihydrolipoyl dehydrogenase"
        },
        {
          "id": 4,
          "text": "Pyruvate carboxylase and dihydrolipoyl dehydrogenase"
        }
      ],
      "correct_choice_id": 1,
      "solution": "<p><strong>E1</strong> is<strong> pyruvate dehydrogenase</strong> and <strong>E2 </strong>is <strong>dihydrolipoyl transacetylase</strong> in the image showing <strong>oxidative decarboxylation of pyruvate. </strong>This is catalyzed by the pyruvate dehydrogenase (PDH) complex where E1, E2, and E3 are the three enzyme components of the complex. </p>\n<p>The pyruvate dehydrogenase (PDH) complex is a <strong>multienzyme complex</strong> that is associated with the inner mitochondrial membrane. It catalyzes the <strong>oxidative decarboxylation</strong> of <strong>pyruvate to acetyl-CoA</strong> which enters the citric acid/Kreb’s cycle. <br /><br /></p>\n<table>\n<tbody>\n<tr>\n<td><strong>Enzyme components of PDH complex</strong></td>\n<td><strong>                       Co-factors</strong></td>\n</tr>\n<tr>\n<td>Pyruvate dehydrogenase (E1)</td>\n<td>Thiamine pyrophosphate (TPP)</td>\n</tr>\n<tr>\n<td>Dihydrolipoyl transacetylase (E2)</td>\n<td>\n<p>Lipoic acid</p>\n<p>Coenzyme A</p>\n</td>\n</tr>\n<tr>\n<td>Dihydrolipoyl dehydrogenase (E3)</td>\n<td>\n<p>Flavin adenine dinucleotide (FAD)</p>\n<p>Nicotinamide adenine dinucleotide (NAD+)</p>\n</td>\n</tr>\n</tbody>\n</table><div class=\"table-expand-wrapper\"><button type=\"button\" class=\"table-expand-btn glass-light\">Expand Table</button></div>\n<p><br />Steps of pyruvate decarboxylation:</p>\n<ul>\n<li aria-level=\"1\">Pyruvate is transported into the<strong> mitochondria</strong> by a proton symporter.</li>\n<li aria-level=\"1\">Pyruvate is decarboxylated by <strong>pyruvate dehydrogenase (E1)</strong>. <strong>TPP</strong> is required for this step. The decarboxylated pyruvate remains bound to the enzyme, as hydroxyethyl thiamine pyrophosphate.</li>\n<li aria-level=\"1\">The hydroxyethyl group is oxidized to form an acetyl group. It is then transferred from TPP to <strong>lipoamide</strong> to form <strong>acetyl lipoamide.</strong> This step is catalyzed by <strong>dihydrolipoyl transacetylase</strong> <strong>(E2).</strong></li>\n<li aria-level=\"1\">Acetyl lipoamide reacts with <strong>coenzyme A</strong> to form <strong>acetyl-CoA</strong> and reduced lipoamide. </li>\n<li aria-level=\"1\">The reduced lipoamide is reoxidized by<strong> FAD-dependent</strong> <strong>dihydrolipoyl dehydrogenase (E3).</strong> </li>\n</ul>\n<p>        The overall reaction is : <strong>Pyruvate + NAD<sup>+</sup> + CoA → Acetyl-CoA + NADH + H<sup>+</sup> + CO2</strong></p><img src=\"https://dhmbxeygs57ff.cloudfront.net/uploads/3fdba9494f474323a9c3ab86bcd0234bx1092x899.PNG\" alt=\"Explanation Image\"><p> </p>\n<p>Clinical significance:</p>\n<ol>\n<li aria-level=\"1\"><strong>Dietary deficiency</strong> of <strong>thiamine</strong> inhibits PDH. Chronic alcoholics may develop potentially fatal <strong>pyruvic and lactic acidosis. </strong>Lactic acidosis is a common presentation in patients with<strong> inherited pyruvate dehydrogenase deficiency </strong>too.<strong> </strong></li>\n<li aria-level=\"1\">In <strong>arsenic</strong> and <strong>mercury poisoning</strong>, the heavy metal ions react with -SH groups of lipoic acid and inhibit pyruvate dehydrogenase.</li>\n</ol>\n<p>Other multienzyme complexes include <strong>alpha-ketoglutarate dehydrogenase</strong> and <strong>branched-chain ketoacid dehydrogenase.</strong> All the <strong>five coenzymes</strong> of PDH are <strong>common</strong> to these two complexes too.</p><hr><h3>Related Pearl: Pyruvate metabolism</h3><table>\n<tbody>\n<tr>\n<td>&nbsp;</td>\n<td><strong>Enzyme involved</strong></td>\n<td>\n<p><strong>Fate of pyruvate</strong></p>\n</td>\n</tr>\n<tr>\n<td>1</td>\n<td>Cahill cycle (Alanine aminotransferase)</td>\n<td>\n<p>Carries amino group from muscle to liver.</p>\n<p>Converts alanine to pyruvate and vise-versa.</p>\n</td>\n</tr>\n<tr>\n<td>2</td>\n<td>Pyruvate carboxylase</td>\n<td>Formation of oxaloacetate from pyruvate to be used in the TCA cycle</td>\n</tr>\n<tr>\n<td>3</td>\n<td>Pyruvate dehydrogenase</td>\n<td>Pyruvate to acetyl Co-A to be used in the TCA cycle</td>\n</tr>\n<tr>\n<td>4</td>\n<td>Lactic acid dehydrogenase</td>\n<td>Pyruvate to lactate(Anaerobic glycolysis)</td>\n</tr>\n</tbody>\n</table><div class=\"table-expand-wrapper\"><button type=\"button\" class=\"table-expand-btn glass-light\">Expand Table</button></div>",
      "question_images": [
        "https://cdn1.dailyrounds.org/uploads/72eb71b8612b4f1b9d3f4db4baaaf704.JPEG"
      ],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MF1336",
      "difficulty": "medium"
    },
    {
      "text": "A young girl presented to the OPD for examination. She is tall and thin with slender fingers, and dislocated lenses. Workup revealed cystathionine beta-synthase deficiency. Which amino acid supplement is required in this case?",
      "choices": [
        {
          "id": 1,
          "text": "Cysteine"
        },
        {
          "id": 2,
          "text": "Methionine"
        },
        {
          "id": 3,
          "text": "Serine"
        },
        {
          "id": 4,
          "text": "Tyrosine"
        }
      ],
      "correct_choice_id": 1,
      "solution": "<p>The clinical picture of a tall and thin young girl with slender fingers, dislocated lenses, and cystathionine beta-synthase deficiency is suggestive of <strong>classic homocystinuria.</strong> The amino acid supplement required in this scenario is <strong>cysteine.</strong></p>\n<p>Classic homocystinuria is a metabolic disorder of <strong>methionine metabolism,</strong> due to <strong>cystathionine beta-synthase deficiency</strong>. It is an autosomal recessive condition.</p>\n<p>Cystathionine beta-synthase is a <strong>pyridoxal phosphate-dependent</strong> enzyme that condenses homocysteine with serine to form cystathionine. The absence of this enzyme will cause cysteine deficiency, hence cysteine needs to be supplemented in the diet.</p>\n<p>Clinical features:</p>\n<ul>\n<li>Affected children are initially asymptomatic.&nbsp;</li>\n<li aria-level=\"1\"><strong>Ectopia lentis</strong> (subluxation of the lens) is seen first, after 3 years of age.</li>\n<li aria-level=\"1\">Intellectual disability and psychiatric and behavioral disorders.</li>\n<li aria-level=\"1\">Thromboembolic episodes.</li>\n<li aria-level=\"1\">Skeletal abnormalities resembling those of Marfan syndrome: They are tall and thin with elongated limbs and <strong>arachnodactyly (slender fingers).</strong></li>\n</ul>\n<p><strong>Elevations</strong> of both <strong>methionine</strong> and <strong>homocysteine</strong> in body fluids are the diagnostic laboratory findings. The diagnosis is established by molecular analysis of cystathionine &beta;-synthase (CBS) or by assay of the enzyme in cultured fibroblasts, phytohemagglutinin-stimulated lymphocytes, or liver biopsy specimens. Treatment includes <strong>restriction of methionine intake</strong> and supplementation with <strong>cysteine, betaine, vitamins B6, B12,</strong> and <strong>folate.</strong></p><img src=\"https://dhmbxeygs57ff.cloudfront.net/uploads/00fc56d26bed4db181a849c7dbef250ex1280x1774.JPEG\" alt=\"Explanation Image\"><p>&nbsp;</p>\n<p>The image below shows arachnodactyly.&nbsp;</p><img src=\"https://dhmbxeygs57ff.cloudfront.net/uploads/bcd76df2f7cd4fd8bcc986803f0c1256x512x345.PNG\" alt=\"Explanation Image\"><p>&nbsp;<strong>Methionine supplementation</strong> is required in<strong> non-classical homocystinuria.</strong> It is due to impaired re-methylation of homocysteine to methionine. This can be caused by <strong>defective methionine synthase</strong> or <strong>reduced availability</strong> of two essential cofactors, 5-<strong>methyltetrahydrofolate,</strong> and<strong> methylcobalamin.</strong></p>\n<p><strong>Elevated homocysteine</strong> levels with <strong>low</strong> levels of <strong>methionine</strong> will be seen. Treatment includes <strong>methionine supplementation</strong> and administration of methyl folate, hydroxocobalamin, and betaine.</p><hr><h3>Related Pearl: Homocystinuria</h3><img src=\"https://dhmbxeygs57ff.cloudfront.net/uploads/c84307c25b08404ebad0ed6c97f95b35x1280x1169.JPEG\" alt=\"Pearl Image\"><p>The concept for treatment:</p>\n<ul>\n<li>Since homocysteine is produced from methionine, decreased dietary intake of methionine decreases the formation of homocysteine.</li>\n<li>As the end product of this cycle is cysteine, increased dietary intake of cysteine will decrease the conversion of methionine to homocysteine through negative feedback.</li>\n</ul><hr><h3>Related Pearl: Amino acid Enzymatic Disorders and the Associated Enzymes</h3><table>\n<tbody>\n<tr>\n<td>\n<p><strong>Disorder</strong></p>\n</td>\n<td>\n<p><strong>Enzyme defect</strong></p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Phenylketonuria</p>\n</td>\n<td>\n<p>Phenylalanine hydroxylase</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Tyrosinosis (Tyrosinemia type I)</p>\n</td>\n<td>\n<p>Maleyl Acetate isomerase or Fumarylacetoacetate hydrolase</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Maple syrup urine disease&nbsp;</p>\n</td>\n<td>\n<p>Branched-chain alpha-keto acid dehydrogenase(BCKAD)</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Alkaptonuria</p>\n</td>\n<td>\n<p>Homogentisate oxidase</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Albinism</p>\n</td>\n<td>\n<p>Tyrosinase</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Homocystinuria type I</p>\n</td>\n<td>\n<p>Cystathionine synthase</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Homocystinuria type II</p>\n</td>\n<td>\n<p>Defect in methylcobalamin formation</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Cystathioninuria</p>\n</td>\n<td>\n<p>Cystathionase</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Tyrosinemia type II or Richner-Hanhart syndrome</p>\n</td>\n<td>\n<p>Tyrosine transaminase or Tyrosine aminotransferase</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Primary hyperoxaluria</p>\n</td>\n<td>\n<p>Alanine glyoxalate aminotransferase</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Hypervalinemia</p>\n</td>\n<td>\n<p>Valine transaminase</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Isovaleric acidemia</p>\n</td>\n<td>\n<p>Isovaleryl CoA dehydrogenase</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Histidinemia</p>\n</td>\n<td>\n<p>Histidase</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Hyperprolinemia type I</p>\n</td>\n<td>\n<p>Proline oxidase</p>\n</td>\n</tr>\n</tbody>\n</table><div class=\"table-expand-wrapper\"><button type=\"button\" class=\"table-expand-btn glass-light\">Expand Table</button></div>\n<p>&nbsp;</p>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MF1318",
      "difficulty": "medium"
    },
    {
      "text": "A patient presented with joint pain and on evaluation, urine turns black on standing. What is the likely enzyme deficiency?",
      "choices": [
        {
          "id": 1,
          "text": "Homogentisic acid 1, 2 - dioxygenase"
        },
        {
          "id": 2,
          "text": "Tyrosine transaminase"
        },
        {
          "id": 3,
          "text": "Fumarylacetoacetate hydrolase"
        },
        {
          "id": 4,
          "text": "4-hydroxy-phenyl pyruvate dioxygenase"
        }
      ],
      "correct_choice_id": 1,
      "solution": "<p>The urine turning black in color, on exposure to air, along with joint pain is suggestive of <strong>alkaptonuria.</strong> It occurs due to the defect in the<strong> homogentisic acid 1, 2 - dioxygenase</strong> enzyme.</p>\n<p>Alkaptonuria is an autosomal recessive disorder of <strong>tyrosine metabolism</strong>, that develops due to the defect in <strong>homogentisate oxidase/homogentisic acid 1, 2 - dioxygenase</strong>, which oxidizes homogentisate to maleylacetoacetate.&nbsp;The defect in this enzyme leads to the accumulation of homogentisate, which is then excreted in the urine.&nbsp;</p>\n<p>Alkaptonuria is characterized by homogentisic aciduria, ochronosis, and arthropathy (joint pain).</p>\n<p><strong>Homogentisic aciduria</strong> is the black discoloration of urine on prolonged exposure to air caused due to oxidation of the excreted homogentisate.&nbsp;</p>\n<p><strong>Ochronosis</strong> is the accumulation of oxidized homogentisic acid pigment (alkaptone bodies) in connective tissues leading to bluish-black discoloration of tissues mostly involving ear cartilage, ocular tissue, the skin of the eyelids, forehead, cheeks, and hands, nail beds, and intervertebral discs.&nbsp;The compound that accumulates in the tissues in ochronosis is&nbsp;<strong>benzoquinone acetate</strong>.</p>\n<p><strong>Painful arthritis (arthropathy)</strong> may be seen from the fourth or fifth decade.</p>\n<p><strong>Diagnosis:</strong> Blackish discoloration of urine on standing is diagnostic of alkaptonuria (shown below). The ferric chloride test<strong>&nbsp;</strong>will be positive.</p>\n<p>The image further below shows Ochronosis.&nbsp;</p><img src=\"https://dhmbxeygs57ff.cloudfront.net/uploads/e0b6a40930e24d548edfd4cc31a67848x512x358.PNG\" alt=\"Explanation Image\"><img src=\"https://dhmbxeygs57ff.cloudfront.net/uploads/a065d74217404dac831f4af6fe3abb37x720x401.PNG\" alt=\"Explanation Image\"><p>&nbsp;</p>\n<p><strong>Treatment:</strong>&nbsp; No specific treatment is required. Symptomatic treatment with analgesics, spinal surgery, and arthroplasty along with ascorbic acid and protein restriction can be considered.&nbsp;<strong>Nitisinone</strong> (p-hydroxyphenylpyruvic acid (pHPPA) oxidase inhibitor) reduces urinary excretion of homogentisic acid.</p>\n<p>Other options:</p>\n<p>Option B: <strong>Tyrosine transaminase</strong> deficiency causes <strong>type II tyrosinemia</strong> (Richner-Hanhart syndrome). Patients present with painful corneal erosions with photophobia, learning disability, and palmoplantar keratosis.</p>\n<p>Option C: <strong>Fumarylacetoacetate hydrolase</strong> deficiency causes <strong>type I tyrosinemia</strong> (Tyrosinosis). Patients generally present with failure to thrive, neuropathy,&nbsp;<strong>boiled-cabbage urine,&nbsp;</strong>and liver failure secondary to cirrhosis.</p>\n<p>Option D:&nbsp;<strong> 4-hydroxy-phenyl pyruvate dioxygenase deficiency</strong> causes <strong>type III tyrosinemia</strong> (neonatal tyrosinemia). Patients might rarely have a mental disability. The liver function is generally normal.&nbsp;</p>\n<p>The steps of tyrosine metabolism are shown below.</p>\n<p>&nbsp;</p><img src=\"https://dhmbxeygs57ff.cloudfront.net/uploads/48a2de60b7cd42e09999616286e8a155x1280x2566.JPEG\" alt=\"Explanation Image\"><hr><h3>Related Pearl: Amino acid Enzymatic Disorders and the Associated Enzymes</h3><table>\n<tbody>\n<tr>\n<td>\n<p><strong>Disorder</strong></p>\n</td>\n<td>\n<p><strong>Enzyme defect</strong></p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Phenylketonuria</p>\n</td>\n<td>\n<p>Phenylalanine hydroxylase</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Tyrosinosis (Tyrosinemia type I)</p>\n</td>\n<td>\n<p>Maleyl Acetate isomerase or Fumarylacetoacetate hydrolase</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Maple syrup urine disease&nbsp;</p>\n</td>\n<td>\n<p>Branched-chain alpha-keto acid dehydrogenase(BCKAD)</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Alkaptonuria</p>\n</td>\n<td>\n<p>Homogentisate oxidase</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Albinism</p>\n</td>\n<td>\n<p>Tyrosinase</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Homocystinuria type I</p>\n</td>\n<td>\n<p>Cystathionine synthase</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Homocystinuria type II</p>\n</td>\n<td>\n<p>Defect in methylcobalamin formation</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Cystathioninuria</p>\n</td>\n<td>\n<p>Cystathionase</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Tyrosinemia type II or Richner-Hanhart syndrome</p>\n</td>\n<td>\n<p>Tyrosine transaminase or Tyrosine aminotransferase</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Primary hyperoxaluria</p>\n</td>\n<td>\n<p>Alanine glyoxalate aminotransferase</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Hypervalinemia</p>\n</td>\n<td>\n<p>Valine transaminase</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Isovaleric acidemia</p>\n</td>\n<td>\n<p>Isovaleryl CoA dehydrogenase</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Histidinemia</p>\n</td>\n<td>\n<p>Histidase</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Hyperprolinemia type I</p>\n</td>\n<td>\n<p>Proline oxidase</p>\n</td>\n</tr>\n</tbody>\n</table><div class=\"table-expand-wrapper\"><button type=\"button\" class=\"table-expand-btn glass-light\">Expand Table</button></div>\n<p>&nbsp;</p><hr><h3>Related Pearl: Color of urine  in different conditions</h3><p>Normal color of urine is <strong>pale straw</strong> due to presence of <strong>urochrome.</strong></p>\n<table>\n<tbody>\n<tr>\n<td><strong>Abnormality</strong></td>\n<td><strong>Cause</strong></td>\n</tr>\n<tr>\n<td>Smokey or cloudy</td>\n<td>\n<ul>\n<li>AGN</li>\n<li>Nephrotic syndrome</li>\n</ul>\n</td>\n</tr>\n<tr>\n<td>Gross blood</td>\n<td>\n<ul>\n<li>Urological causes&nbsp; &nbsp; &nbsp;</li>\n<li>Nephro causes</li>\n<li>Hematological causes, e.g. PNH</li>\n</ul>\n</td>\n</tr>\n<tr>\n<td>Red without blood [brownish tinge]</td>\n<td>\n<ul>\n<li>Rhabdomyolysis&nbsp; &nbsp;</li>\n<li>Beetroot ingestion&nbsp;</li>\n</ul>\n</td>\n</tr>\n<tr>\n<td>Tea- or cola-colored urine</td>\n<td>Hemoglobinuria</td>\n</tr>\n<tr>\n<td>High-colored urine</td>\n<td>Bilirubinuria</td>\n</tr>\n<tr>\n<td>Darkens on standing</td>\n<td>Alkaptonuria</td>\n</tr>\n</tbody>\n</table><div class=\"table-expand-wrapper\"><button type=\"button\" class=\"table-expand-btn glass-light\">Expand Table</button></div>\n<p>&nbsp;</p>\n<p>&nbsp;Due to Drugs:&nbsp;</p>\n<table>\n<tbody>\n<tr>\n<td><strong>Abnormality&nbsp;</strong></td>\n<td><strong>Drugs&nbsp;</strong></td>\n</tr>\n<tr>\n<td>Orange</td>\n<td>\n<ul>\n<li>Rifamycins (rifampicin, rifabutin, rifapentine)</li>\n<li>B-complex&nbsp;</li>\n</ul>\n</td>\n</tr>\n<tr>\n<td>Blue</td>\n<td>\n<ul>\n<li>Amitriptyline</li>\n<li>Methylene blue</li>\n<li>Copper poisoning</li>\n</ul>\n</td>\n</tr>\n<tr>\n<td>Brown</td>\n<td>\n<ul>\n<li>Chloroquine</li>\n<li>Quinine</li>\n<li>Primaquine</li>\n<li>Nitrofurantoin&nbsp;</li>\n</ul>\n</td>\n</tr>\n<tr>\n<td>Yellow</td>\n<td>Tetracycline&nbsp;</td>\n</tr>\n<tr>\n<td>Pinkish</td>\n<td>Deferoxamine</td>\n</tr>\n<tr>\n<td>Green</td>\n<td>Triamterene</td>\n</tr>\n<tr>\n<td>Darkens on standing</td>\n<td>\n<ul>\n<li>Metronidazole</li>\n<li>Methyldopa</li>\n<li>Imipenem-cilastin</li>\n</ul>\n</td>\n</tr>\n</tbody>\n</table><div class=\"table-expand-wrapper\"><button type=\"button\" class=\"table-expand-btn glass-light\">Expand Table</button></div>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MF1328",
      "difficulty": "easy"
    },
    {
      "text": "A 5-year-old boy presented with easy fatigability, irritability and inability to concentrate. Labs revealed the following findings a and b (light and oil immersion respectively) on the bone marrow aspiration. Which of the following is the most likely enzyme deficient in this condition?",
      "choices": [
        {
          "id": 1,
          "text": "Hexosaminidase"
        },
        {
          "id": 2,
          "text": "Glucocerebrosidase"
        },
        {
          "id": 3,
          "text": "Sphingomyelinase"
        },
        {
          "id": 4,
          "text": "N-acetylglucosaminidase"
        }
      ],
      "correct_choice_id": 2,
      "solution": "<p>The given clinical scenario of a child with easy fatiguability, irritability, and inability to concentrate with the images showing a <strong>crumpled tissue paper</strong> appearance(Gaucher's cell) is suggestive of <strong>Gaucher's disease.</strong> The deficient enzyme is <strong>glucocerebrosidase</strong> (also known as beta-glucosidase). I</p>\n<p>Gaucher's disease is an inborn error of metabolism caused due to a deficiency of <strong>beta glucocerebrosidase</strong>. It is the most common <strong>lysosomal storage disorder</strong> and the mode of inheritance is <strong>autosomal recessive</strong>. There is an accumulation of lipid-laden macrophages in the spleen, liver, and other tissues.</p>\n<p>There are three clinical subtypes - type I (chronic non-neuronopathic), type II (acute neuronopathic), and type III (intermediate). Clinical features include anemia, thrombocytopenia, hepatosplenomegaly, and neurological features depending on the subtype. </p>\n<p><strong>Gaucher's cells</strong> - These are formed as a result of the accumulation of massive amounts of glucocerebrosides within the phagocytes. The cells have a fibrillary cytoplasm and give a <strong>crumpled tissue paper appearance</strong>.</p><p>Option A: Deficiency of beta-<strong>hexosaminidase</strong> A is seen in <strong>Tay-Sachs</strong> disease. The deficiency of <strong>beta-hexosaminidase A and B</strong> causes<strong> Sandhoff's disease</strong>. Clinical features are seizures, macrocephaly, and hyperacusis. </p>\n<p>Option C: Deficiency of sphingomyelinase leads to <strong>Niemann-Pick </strong>disease. It is characterized by the presence of <strong>foam cells</strong> in the bone marrow. There may be pulmonary infiltrates leading to lung failure. </p>\n<p>Option D:<strong> </strong>Deficiency of<strong> N-acetylglucosaminidase</strong> leads to <strong>Sanfillipo's</strong> disease. It is a type of mucopolysaccharidosis (MPS - III). There is an accumulation of heparan sulfate leading to severe cognitive degeneration.</p><hr><h3>Related Pearl: Examples of Sphingolipidoses (Lipids-Storage Disease)</h3><img src=\"https://dhmbxeygs57ff.cloudfront.net/uploads/eaf86bca861342ff84c303230efbb8bax1280x2017.JPEG\" alt=\"Pearl Image\"><table>\n<tbody>\n<tr>\n<td>\n<p><strong>S. No.</strong></p>\n</td>\n<td>\n<p><strong>Disease</strong></p>\n</td>\n<td>\n<p><strong>Enzyme Deficiency</strong></p>\n</td>\n<td>\n<p><strong>Lipid </strong></p>\n<p><strong>Accumulating</strong></p>\n</td>\n<td>\n<p><strong>Clinical Symptoms</strong></p>\n</td>\n</tr>\n<tr>\n<td>\n<p>1</p>\n</td>\n<td>\n<p>Tay–Sachs disease</p>\n</td>\n<td>\n<p>Hexosaminidase A</p>\n</td>\n<td>\n<p>Ganglioside</p>\n</td>\n<td>\n<p>Mental retardation, blindness, muscular weakness</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>2</p>\n</td>\n<td>\n<p>Sandhoff's disease</p>\n</td>\n<td>\n<p>Hexosaminidase A and B</p>\n</td>\n<td>\n<p>Globoside &amp; Ganglioside</p>\n</td>\n<td>\n<p>Similar to Tay–Sachs disease but also has hepatosplenomegaly and skeletal dysplasias</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>3</p>\n</td>\n<td>\n<p>Fabry's disease</p>\n</td>\n<td>\n<p>α-Galactosidase</p>\n</td>\n<td>\n<p>Globotriaosyl-ceramide</p>\n</td>\n<td>\n<p>Skin rash, kidney failure (full symptoms only in males; X-linked recessive)</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>4</p>\n</td>\n<td>\n<p>Metachromatic leukodystrophy</p>\n</td>\n<td>\n<p>Arylsulfatase A</p>\n</td>\n<td>\n<p>3-Sulfogalactosyl-ceramide</p>\n</td>\n<td>\n<p>Mental retardation and psychologic disturbances in adults; demyelination</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>5</p>\n</td>\n<td>\n<p>Krabbe disease</p>\n</td>\n<td>\n<p>β-Galactosidase</p>\n</td>\n<td>\n<p>Galactosylceramide</p>\n</td>\n<td>\n<p>Mental retardation; myelin almost absent</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>6</p>\n</td>\n<td>\n<p>Gaucher's disease</p>\n</td>\n<td>\n<p>β-Glucosidase</p>\n</td>\n<td>\n<p>Glucosylceramide</p>\n</td>\n<td>\n<p>Enlarged liver and spleen, erosion of long bones, mental retardation in infants</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>7</p>\n</td>\n<td>\n<p>Niemann–Pick disease</p>\n</td>\n<td>\n<p>Sphingomyelinase</p>\n</td>\n<td>\n<p>Sphingomyelin</p>\n</td>\n<td>\n<p>Enlarged liver and spleen, mental retardation; fatal in early life</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>8</p>\n</td>\n<td>\n<p>Farber's disease</p>\n</td>\n<td>\n<p>Ceramidase</p>\n</td>\n<td>\n<p>Ceramide</p>\n</td>\n<td>\n<p>Hoarseness, dermatitis, skeletal deformation, mental retardation; fatal in early life</p>\n</td>\n</tr>\n</tbody>\n</table><div class=\"table-expand-wrapper\"><button type=\"button\" class=\"table-expand-btn glass-light\">Expand Table</button></div>",
      "question_images": [
        "https://cdn1.dailyrounds.org/uploads/12f46ebde0b240f18423e6ca63d55aeb.JPEG"
      ],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MF1500",
      "difficulty": "easy"
    },
    {
      "text": "A farmer presented with loose stools and rashes over the sun-exposed areas. Careful diet history reveals a diet rich in maize. Which of the following deficiencies would you suspect?",
      "choices": [
        {
          "id": 1,
          "text": "Niacin"
        },
        {
          "id": 2,
          "text": "Pyridoxine"
        },
        {
          "id": 3,
          "text": "Thiamine"
        },
        {
          "id": 4,
          "text": "Biotin"
        }
      ],
      "correct_choice_id": 1,
      "solution": "<p>History of a <strong>maize-rich diet</strong> along with <strong>loose stools</strong> and <strong>rashes over the sun-exposed areas</strong> is suggestive of <strong>niacin/vitamin B3 deficiency.</strong></p>\n<p>Niacin deficiency causes <strong>pellagra,</strong> found mostly among people eating <strong>corn/maize-based diets</strong>, which is <strong>low in niacin</strong> and <strong>tryptophan.</strong> <strong>Excess leucine</strong> in jowar and maize disrupts the conversion of tryptophan to niacin.</p>\n<p>Niacin can be synthesized in the body from tryptophan. Two compounds- nicotinic acid, and nicotinamide have the biological activity of niacin.&nbsp;The nicotinamide ring of the coenzymes<strong> NAD</strong> ( nicotinamide adenine dinucleotide) and <strong>NADP</strong> (nicotinamide adenine dinucleotide phosphate) participate in oxidation/reduction reactions.</p>\n<p>The initial symptoms of pellagra include loss of appetite, generalized weakness, irritability, abdominal pain, and vomiting. This is followed by <strong>bright red glossitis</strong> and a characteristic pigmented, scaly skin rash in sun-exposed areas. This rash is known as <strong>Casal&rsquo;s necklace</strong> when it forms a ring around the neck.&nbsp;</p>\n<p>The 4Ds of pellagra:</p>\n<ul>\n<li aria-level=\"1\"><strong>D</strong>iarrhea</li>\n<li aria-level=\"1\"><strong>D</strong>ermatitis</li>\n<li aria-level=\"1\"><strong>D</strong>ementia, leading to</li>\n<li aria-level=\"1\"><strong>D</strong>eath</li>\n</ul>\n<p>It is diagnosed by measuring<strong> urinary levels</strong> of <strong>2-methyl nicotinamide</strong> and <strong>2-pyridone.</strong></p>\n<p>It is treated by oral supplementation of 100&ndash;200 mg of <strong>nicotinamide</strong> or <strong>nicotinic acid</strong> three times daily for 5 days.</p><p>Casal&rsquo;s necklace finding in niacin deficiency</p><img src=\"https://dhmbxeygs57ff.cloudfront.net/uploads/6cf4030a592c46fead09e9edf9399244x720x521.JPEG\" alt=\"Explanation Image\"><p>Other options:&nbsp;</p>\n<p>Option B: Dietary <strong>pyridoxine deficiency</strong> (vitamin B6) is rare but has been observed in alcoholics, newborn infants formulas low in vitamin B6, and women taking oral contraceptives.<strong> Isoniazid,</strong> an anti-TB drug, leads to pyridoxine deficiency resulting in <strong>peripheral neuropathy.</strong> Hence pyridoxine supplementation is included in ATT regimens.</p>\n<p>Option C: <strong>Thiamine deficiency</strong> (vitamin B1) can manifest as<strong> wet beriberi</strong> (CVS features like heart failure and edema) or <strong>Shoshin beriberi</strong>, an acute and fulminant form of wet beriberi, <strong>dry beriberi</strong> (peripheral neuritis), or as <strong>Wernicke encephalopathy</strong> with Korsakoff psychosis (in alcoholics).&nbsp;<strong>Dietary deficiency</strong>&nbsp;of&nbsp;<strong>thiamine</strong>&nbsp;inhibits pyruvate dehydrogenase. Chronic alcoholics may develop potentially fatal&nbsp;<strong>pyruvic and lactic acidosis.&nbsp;</strong></p>\n<p>Option D: Dietary<strong> biotin deficiency</strong> is unknown but rarely, dermatitis, glossitis, loss of appetite, and nausea may occur after consumption of large amounts of <strong>uncooked egg white</strong>, which contains the protein <strong>avidin.</strong> It binds biotin and makes it unavailable for absorption.</p>\n<p>Note: A similar image-based question on vitamin B3 deficiency was previously asked in NEET PG 2020. Vitamin deficiencies are a high-yield topic and are repeatedly tested every year.</p><hr><h3>Related Pearl: Vitamin Deficiency States (Water-soluble Vitamins)</h3><table>\n<tbody>\n<tr>\n<td>\n<p><strong>Vitamin</strong></p>\n</td>\n<td>\n<p><strong>Deficiency State</strong></p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Thiamine (<strong>B<sub>1</sub></strong>)</p>\n</td>\n<td>\n<p><strong>Beriberi</strong></p>\n<p>Wernicke&ndash;Korsakoff&rsquo;s syndrome</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Riboflavin (<strong>B<span>2</span></strong>)</p>\n</td>\n<td>\n<p>Cheilosis, Magenta-coloured tongue,&nbsp;</p>\n<p>Glossitis, Seborrheic dermatitis</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Niacin (<strong>B<span>3</span></strong>)</p>\n</td>\n<td>\n<p><strong>Pellagra</strong></p>\n<p>Dermatitis, Diarrhea, Dementia</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Pantothenic acid (<strong>B<span>5</span></strong>)</p>\n</td>\n<td>\n<p><strong>Burning foot syndrome</strong> (historically called as \"Nutritional melalgia\")</p>\n<div class=\"page\" title=\"Page 90\">\n<div class=\"section\">\n<div class=\"layoutArea\">\n<div class=\"column\">\n<p>Dermatitis, enteritis, alopecia, ataxia</p>\n</div>\n</div>\n</div>\n</div>\n</td>\n</tr>\n<tr>\n<td>\n<p>Pyridoxine (<strong>B<span>6</span></strong>)</p>\n</td>\n<td>\n<p>Microcytic anemia, convulsions, depression</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Biotin (<strong>B<span>7</span></strong>)</p>\n</td>\n<td>\n<p>Relatively unknown</p>\n<p>Dermatitis, atrophic glossitis, alopecia, paraesthesia, muscle pain, anorexia, hallucinations</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Folic acid (<strong>B<span>9</span></strong>)</p>\n</td>\n<td>\n<p>Megaloblastic anemia, neuropathy, neural tube defects, atrophic glossitis</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Cobalamin (<strong>B<span>12</span></strong>)</p>\n</td>\n<td>\n<p>Pernicious anemia, dementia, spinal cord degeneration, homocysteinemia</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Ascorbic acid (<strong>C</strong>)</p>\n</td>\n<td>\n<p><strong>Scurvy</strong></p>\n<p>Ecchymosis, bleeding gums, poor wound healing, fatigue, joint effusion, Scorbutic rosary</p>\n</td>\n</tr>\n</tbody>\n</table><div class=\"table-expand-wrapper\"><button type=\"button\" class=\"table-expand-btn glass-light\">Expand Table</button></div><hr><h3>Related Pearl: Conditions Associated with Pellagra-like Symptoms</h3><table>\n<tbody>\n<tr>\n<td>\n<p><strong>Condition/Disease</strong></p>\n</td>\n<td>\n<p><strong>Reason for niacin deficiency</strong></p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Hartnup disease</p>\n</td>\n<td>\n<p>Intestinal &amp; renal malabsorption of tryptophan</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Carcinoid syndrome</p>\n</td>\n<td>\n<p>Overproduction of serotonin that causes diversion of  tryptophan from NAD+ Pathway</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Vitamin B6 deficiency</p>\n</td>\n<td>\n<p>Defective kynureninase pathway</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Maize rich diet</p>\n</td>\n<td>\n<p>Niacin is in unavailable niacytin form</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Jowar diet (Sorghum)</p>\n</td>\n<td>\n<p>Increase leucine content inhibit QPRTase enzyme</p>\n</td>\n</tr>\n</tbody>\n</table><div class=\"table-expand-wrapper\"><button type=\"button\" class=\"table-expand-btn glass-light\">Expand Table</button></div>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MF1332",
      "difficulty": "easy"
    }
  ]
}